Format

Send to

Choose Destination
Ann Oncol. 2017 Jan 1;28(1):16-33. doi: 10.1093/annonc/mdw544.

3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3).

Author information

1
European School of Oncology & Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal.
2
European School of Oncology, Milan, Italy and European School of Oncology, Bellinzona, Switzerland.
3
Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland.
4
Breast Center, Genolier Cancer Center, Genolier, Switzerland.
5
Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France.
6
Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil.
7
Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden.
8
Department of Medical Oncology, Fortis Hospital, Kolkata, India.
9
Medical Oncology Department, Hospital of Prato, Prato, Italy.
10
Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal.
11
Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center.
12
METAvivor Research and Support, Annapolis, USA.
13
Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy.
14
Department of Medical Oncology, Institut Curie, Paris, France.
15
NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut, Beirut, Lebanon.
16
Department of Breast Tumors, Cancer Institute 'I. Chiricuta', Cluj-Napoca, Romania.
17
Brighton & Sussex Medical School, University of Sussex, Falmer, UK.
18
Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta.
19
Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia.
20
BC Cancer Agency, Vancouver Cancer Centre, Vancouver, Canada.
21
Department of Medical Oncology, Galliera Hospital, Genoa, Italy.
22
Brustzentrum der Universitat München, Munich, Germany.
23
Breast Medicine Service, Memorial Sloan-Kettering Cancer Centre, New York, USA.
24
Sheba Medical Center, Tel Hashomer, Israel.
25
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston.
26
Advanced Breast Cancer.org, New York, USA.
27
Department of Radiation Oncology, Radvoud University Medical Center, Nijmegen, The Netherlands.
28
Metastatic Breast Cancer Network US, Inversness, USA.
29
Breast Oncology Centre, Cancer Institute Hospital, Tokyo, Japan.
30
Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland.
31
Europa Donna, Nicosia, Cyprus.
32
European School of Oncology, Milan, Italy and Bellinzona, Switzerland.
33
Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France.
34
Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
35
Department of Medical Oncology, Institut Curie-Université Paris Descartes, Paris, France.
36
Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco.
37
Department of Surgery and Oncology, Johns Hopkins Breast Center, Baltimore.
38
Indiana University Medical CTR, Indianapolis.
39
Lombardi Comprehensive Cancer Center, Georgetown University, Washington, USA.
40
Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, Germany.
41
Breakthrough Breast Cancer Research Unit, King's College London and Guy's and St Thomas's NHS Foundation Trust, London, UK.
42
Sandton Oncology Centre, Johannesburg, South Africa.
43
Department of Medical Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
44
Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York.
45
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA.
PMID:
28177437
PMCID:
PMC5378224
DOI:
10.1093/annonc/mdw544
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center